TP53 and neoplasm: When stratifying by tumor stage and p53 status, the expression of AA-NAT decreased significantly (p < 0.05) in advanced versus early stage tumors (Figure 2A), whereas the expression of MT1 and MT2 did not change in all patients (Figure 2B,C).